These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lactic acidosis and symptomatic hyperlactataemia in a randomized trial of first-line therapy in HIV-infected adults in South Africa. Dlamini J, Ledwaba L, Mokwena N, Mokhathi T, Orsega S, Tsoku M, Kowo H, Proschan M, Khabo P, Maja P, Hadigan C. Antivir Ther; 2011; 16(4):605-9. PubMed ID: 21685549 [Abstract] [Full Text] [Related]
3. Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. Gérard Y, Maulin L, Yazdanpanah Y, De La Tribonnière X, Amiel C, Maurage CA, Robin S, Sablonnière B, Dhennain C, Mouton Y. AIDS; 2000 Dec 01; 14(17):2723-30. PubMed ID: 11125891 [Abstract] [Full Text] [Related]
5. Natural history of hyperlactataemia in human immunodeficiency virus-1-infected patients during highly active antiretroviral therapy. Huynh TK, Lüttichau HR, Roge BT, Gerstoft J. Scand J Infect Dis; 2003 Dec 01; 35(1):62-6. PubMed ID: 12685887 [Abstract] [Full Text] [Related]
7. Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy. Lactic Acidosis International Study Group. AIDS; 2007 Nov 30; 21(18):2455-64. PubMed ID: 18025882 [Abstract] [Full Text] [Related]
8. Matched case-control study to evaluate risk factors for hyperlactataemia in HIV patients on antiretroviral therapy. Datta D, Moyle G, Mandalia S, Gazzard B. HIV Med; 2003 Oct 30; 4(4):311-4. PubMed ID: 14525541 [Abstract] [Full Text] [Related]
14. Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women. Currier JS. Clin Infect Dis; 2007 Jul 15; 45(2):261-2. PubMed ID: 17578789 [No Abstract] [Full Text] [Related]
15. A high incidence of nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis in HIV-infected patients in a South African context. Geddes R, Knight S, Moosa MY, Reddi A, Uebel K, Sunpath H. S Afr Med J; 2006 Aug 15; 96(8):722-4. PubMed ID: 17019496 [Abstract] [Full Text] [Related]
16. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy. Nelson M, Azwa A, Sokwala A, Harania RS, Stebbing J. AIDS; 2008 Jul 11; 22(11):1374-6. PubMed ID: 18580619 [Abstract] [Full Text] [Related]
18. Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial). Feeney ER, Chazallon C, O'Brien N, Meiffrédy V, Goodall RL, Aboulker JP, Cooper DA, Yeni P, Mallon PW, INITIO Trial International Co-ordinating Committee. HIV Med; 2011 Nov 11; 12(10):602-9. PubMed ID: 21599820 [Abstract] [Full Text] [Related]
19. Metabolic acidosis and hepatic steatosis in two HIV-infected patients on stavudine (d4T) treatment. Cornejo-Juárez P, Sierra-Madero J, Volkow-Fernández P. Arch Med Res; 2003 Nov 11; 34(1):64-9. PubMed ID: 12604378 [Abstract] [Full Text] [Related]